Tamoxifen in Preventing Breast Cancer in Women at Increased Risk for Breast Cancer

Stopped early · Phase 2

Conditions studied: Breast Cancer

In brief

RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. The use of tamoxifen may be effective in preventing breast cancer. PURPOSE: This randomized phase II trial is studying tamoxifen to see how well it works compared to placebo in preventing breast cancer in women who are at increased risk for the disease.

Key facts

Study ID

NCT00096369

Run by

University of Texas Southwestern Medical Center

People needed

130

Starts

2000-02-01

Expected to finish

2007-03-15

Last updated by the study team

2019-01-24

Who can join

Age: 35 and older, up to 120. Sex: female. Healthy volunteers: not accepted.

Where it is running

• Oklahoma University Cancer Institute — Oklahoma City, Oklahoma, United States
• Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas — Dallas, Texas, United States
• M.D. Anderson Cancer Center at University of Texas — Houston, Texas, United States
• Cancer Therapy and Research Center — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.